Lazard Asset Management
SRGA

Lazard Asset Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Lazard Asset Management’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-112
Closed -$9K – 1709
2019
Q3 		$9K Buy
+112
New +$12K ﹤0.01% 1322

Other funds holding SRGA

PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
KFO
Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
HPM
HealthCor Partners Management Charleston, South Carolina $50.7M AUM

Lazard Asset Management's SRGA Position: Q4 2019 in Review

Lazard Asset Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q4 2019, closing a stake of 112 shares — an estimated $9K sold.

Lazard Asset Management first reported a position in SRGA in Q3 2019 and held it in 1 quarter. The position peaked at $9K in Q3 2019. 88 funds tracked by Wall St. Rank hold SRGA as of Q4 2019.

  • Lazard Asset Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Lazard Asset Management sold 112 Surgalign Holdings, Inc. Common Stock shares in Q4 2019, an estimated $9K.
  • Lazard Asset Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q3 2019 and held it in 1 quarter.
  • Lazard Asset Management's Surgalign Holdings, Inc. Common Stock position peaked at $9K in Q3 2019.
  • 88 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q4 2019.

Based on Lazard Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.